Filing Details

Accession Number:
0000882104-20-000213
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-22 19:51:33
Reporting Period:
2020-12-21
Accepted Time:
2020-12-22 19:51:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882104 Pdl Biopharma Inc. PDLI Biological Products, (No Disgnostic Substances) (2836) 943023969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277967 Peter John Mclaughlin C/O Pdl Biopharma, Inc.
932 Southwood Blvd.
Incline Village NV 89451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-21 50,000 $2.62 477,934 No 4 S Direct
Common Stock Disposition 2020-12-22 277,934 $2.61 200,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct